Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia Treatment: a Delphi consensus

Standard

Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia Treatment: a Delphi consensus. / Schmiegelow, Kjeld; Attarbaschi, Andishe; Barzilai, Shlomit; Escherich, Gabriele; Frandsen, Thomas Leth; Halsey, Christina; Hough, Rachael; Jeha, Sima; Kato, Motohiro; Liang, Der-Cherng; Mikkelsen, Torben Stamm; Möricke, Anja; Niinimäki, Riitta; Piette, Caroline; Putti, Maria Caterina; Raetz, Elizabeth; Silverman, Lewis B; Skinner, Roderick; Tuckuviene, Ruta; van der Sluis, Inge; Zapotocka, Ester; Ponte di Legno toxicity working group.

in: LANCET ONCOL, Jahrgang 17, Nr. 6, 06.2016, S. e231-9.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Schmiegelow, K, Attarbaschi, A, Barzilai, S, Escherich, G, Frandsen, TL, Halsey, C, Hough, R, Jeha, S, Kato, M, Liang, D-C, Mikkelsen, TS, Möricke, A, Niinimäki, R, Piette, C, Putti, MC, Raetz, E, Silverman, LB, Skinner, R, Tuckuviene, R, van der Sluis, I, Zapotocka, E & Ponte di Legno toxicity working group 2016, 'Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia Treatment: a Delphi consensus', LANCET ONCOL, Jg. 17, Nr. 6, S. e231-9. https://doi.org/10.1016/S1470-2045(16)30035-3

APA

Schmiegelow, K., Attarbaschi, A., Barzilai, S., Escherich, G., Frandsen, T. L., Halsey, C., Hough, R., Jeha, S., Kato, M., Liang, D-C., Mikkelsen, T. S., Möricke, A., Niinimäki, R., Piette, C., Putti, M. C., Raetz, E., Silverman, L. B., Skinner, R., Tuckuviene, R., ... Ponte di Legno toxicity working group (2016). Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia Treatment: a Delphi consensus. LANCET ONCOL, 17(6), e231-9. https://doi.org/10.1016/S1470-2045(16)30035-3

Vancouver

Bibtex

@article{8432fe2d933a445d9b6bbcc7e26b55c8,
title = "Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia Treatment: a Delphi consensus",
abstract = "Although there are high survival rates for children with acute lymphoblastic leukaemia, their outcome is often counterbalanced by the burden of toxic effects. This is because reported frequencies vary widely across studies, partly because of diverse definitions of toxic effects. Using the Delphi method, 15 international childhood acute lymphoblastic leukaemia study groups assessed acute lymphoblastic leukaemia protocols to address toxic effects that were to be considered by the Ponte di Legno working group. 14 acute toxic effects (hypersensitivity to asparaginase, hyperlipidaemia, osteonecrosis, asparaginase-associated pancreatitis, arterial hypertension, posterior reversible encephalopathy syndrome, seizures, depressed level of consciousness, methotrexate-related stroke-like syndrome, peripheral neuropathy, high-dose methotrexate-related nephrotoxicity, sinusoidal obstructive syndrome, thromboembolism, and Pneumocystis jirovecii pneumonia) that are serious but too rare to be addressed comprehensively within any single group, or are deemed to need consensus definitions for reliable incidence comparisons, were selected for assessment. Our results showed that none of the protocols addressed all 14 toxic effects, that no two protocols shared identical definitions of all toxic effects, and that no toxic effect definition was shared by all protocols. Using the Delphi method over three face-to-face plenary meetings, consensus definitions were obtained for all 14 toxic effects. In the overall assessment of outcome of acute lymphoblastic leukaemia treatment, these expert opinion-based definitions will allow reliable comparisons of frequencies and severities of acute toxic effects across treatment protocols, and facilitate international research on cause, guidelines for treatment adaptation, preventive strategies, and development of consensus algorithms for reporting on acute lymphoblastic leukaemia treatment.",
author = "Kjeld Schmiegelow and Andishe Attarbaschi and Shlomit Barzilai and Gabriele Escherich and Frandsen, {Thomas Leth} and Christina Halsey and Rachael Hough and Sima Jeha and Motohiro Kato and Der-Cherng Liang and Mikkelsen, {Torben Stamm} and Anja M{\"o}ricke and Riitta Niinim{\"a}ki and Caroline Piette and Putti, {Maria Caterina} and Elizabeth Raetz and Silverman, {Lewis B} and Roderick Skinner and Ruta Tuckuviene and {van der Sluis}, Inge and Ester Zapotocka and {Ponte di Legno toxicity working group}",
note = "Copyright {\textcopyright} 2016 Elsevier Ltd. All rights reserved.",
year = "2016",
month = jun,
doi = "10.1016/S1470-2045(16)30035-3",
language = "English",
volume = "17",
pages = "e231--9",
journal = "LANCET ONCOL",
issn = "1470-2045",
publisher = "Lancet Publishing Group",
number = "6",

}

RIS

TY - JOUR

T1 - Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia Treatment: a Delphi consensus

AU - Schmiegelow, Kjeld

AU - Attarbaschi, Andishe

AU - Barzilai, Shlomit

AU - Escherich, Gabriele

AU - Frandsen, Thomas Leth

AU - Halsey, Christina

AU - Hough, Rachael

AU - Jeha, Sima

AU - Kato, Motohiro

AU - Liang, Der-Cherng

AU - Mikkelsen, Torben Stamm

AU - Möricke, Anja

AU - Niinimäki, Riitta

AU - Piette, Caroline

AU - Putti, Maria Caterina

AU - Raetz, Elizabeth

AU - Silverman, Lewis B

AU - Skinner, Roderick

AU - Tuckuviene, Ruta

AU - van der Sluis, Inge

AU - Zapotocka, Ester

AU - Ponte di Legno toxicity working group

N1 - Copyright © 2016 Elsevier Ltd. All rights reserved.

PY - 2016/6

Y1 - 2016/6

N2 - Although there are high survival rates for children with acute lymphoblastic leukaemia, their outcome is often counterbalanced by the burden of toxic effects. This is because reported frequencies vary widely across studies, partly because of diverse definitions of toxic effects. Using the Delphi method, 15 international childhood acute lymphoblastic leukaemia study groups assessed acute lymphoblastic leukaemia protocols to address toxic effects that were to be considered by the Ponte di Legno working group. 14 acute toxic effects (hypersensitivity to asparaginase, hyperlipidaemia, osteonecrosis, asparaginase-associated pancreatitis, arterial hypertension, posterior reversible encephalopathy syndrome, seizures, depressed level of consciousness, methotrexate-related stroke-like syndrome, peripheral neuropathy, high-dose methotrexate-related nephrotoxicity, sinusoidal obstructive syndrome, thromboembolism, and Pneumocystis jirovecii pneumonia) that are serious but too rare to be addressed comprehensively within any single group, or are deemed to need consensus definitions for reliable incidence comparisons, were selected for assessment. Our results showed that none of the protocols addressed all 14 toxic effects, that no two protocols shared identical definitions of all toxic effects, and that no toxic effect definition was shared by all protocols. Using the Delphi method over three face-to-face plenary meetings, consensus definitions were obtained for all 14 toxic effects. In the overall assessment of outcome of acute lymphoblastic leukaemia treatment, these expert opinion-based definitions will allow reliable comparisons of frequencies and severities of acute toxic effects across treatment protocols, and facilitate international research on cause, guidelines for treatment adaptation, preventive strategies, and development of consensus algorithms for reporting on acute lymphoblastic leukaemia treatment.

AB - Although there are high survival rates for children with acute lymphoblastic leukaemia, their outcome is often counterbalanced by the burden of toxic effects. This is because reported frequencies vary widely across studies, partly because of diverse definitions of toxic effects. Using the Delphi method, 15 international childhood acute lymphoblastic leukaemia study groups assessed acute lymphoblastic leukaemia protocols to address toxic effects that were to be considered by the Ponte di Legno working group. 14 acute toxic effects (hypersensitivity to asparaginase, hyperlipidaemia, osteonecrosis, asparaginase-associated pancreatitis, arterial hypertension, posterior reversible encephalopathy syndrome, seizures, depressed level of consciousness, methotrexate-related stroke-like syndrome, peripheral neuropathy, high-dose methotrexate-related nephrotoxicity, sinusoidal obstructive syndrome, thromboembolism, and Pneumocystis jirovecii pneumonia) that are serious but too rare to be addressed comprehensively within any single group, or are deemed to need consensus definitions for reliable incidence comparisons, were selected for assessment. Our results showed that none of the protocols addressed all 14 toxic effects, that no two protocols shared identical definitions of all toxic effects, and that no toxic effect definition was shared by all protocols. Using the Delphi method over three face-to-face plenary meetings, consensus definitions were obtained for all 14 toxic effects. In the overall assessment of outcome of acute lymphoblastic leukaemia treatment, these expert opinion-based definitions will allow reliable comparisons of frequencies and severities of acute toxic effects across treatment protocols, and facilitate international research on cause, guidelines for treatment adaptation, preventive strategies, and development of consensus algorithms for reporting on acute lymphoblastic leukaemia treatment.

U2 - 10.1016/S1470-2045(16)30035-3

DO - 10.1016/S1470-2045(16)30035-3

M3 - SCORING: Journal article

C2 - 27299279

VL - 17

SP - e231-9

JO - LANCET ONCOL

JF - LANCET ONCOL

SN - 1470-2045

IS - 6

ER -